The role of CD40 and CD154/CD40L in dendritic cells

被引：342

作者：

Ma, Daphne Y. ^{[1
]}

Clark, Edward A. ^{[1
]}

机构：

[1] Univ Washington, Dept Immunol, Seattle, WA 98195 USA

来源：

SEMINARS IN IMMUNOLOGY | 2009年 / 21卷 / 05期

关键词：

CD40; CD40L; CD154; Dendritic cells; NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; CD40-INDUCED GENE-EXPRESSION; X-LINKED IMMUNODEFICIENCY; ACTIVATED PROTEIN-KINASE; TNF FAMILY-MEMBER; T-CELL; FACTOR RECEPTOR; IMMUNE-RESPONSES; CD40/CD154; INTERACTIONS;

D O I：

10.1016/j.smim.2009.05.010

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

In this review, we focus on the function of CD40-CD40L (CD154) interactions in the regulation of dendritic cell (DC)-T cell and DC-B cell crosstalk. In addition, we examine differences and similarities between the CD40 signaling pathway in DCs and other innate immune cell receptors, and how these pathways integrate DC functions. As research into DC vaccines and immunotherapies progresses, further understanding of CD40 and DC function will advance the applicability of DCs in immunotherapy for human diseases. (C) 2009 Elsevier Ltd. All rights reserved.

引用

页码：265 / 272

页数：8

共 131 条

[1] Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting autoimmune diabetes [J].

Adorini, L .

IMMUNE MECHANISMS AND DISEASE, 2003, 987 :258-261

[2]

Aicher A, 1999, J IMMUNOL, V163, P5786

[3] CD40 LIGAND GENE DEFECTS RESPONSIBLE FOR X-LINKED HYPER-IGM SYNDROME [J].

ALLEN, RC ;

ARMITAGE, RJ ;

CONLEY, ME ;

ROSENBLATT, H ;

JENKINS, NA ;

COPELAND, NG ;

BEDELL, MA ;

EDELHOFF, S ;

DISTECHE, CM ;

SIMONEAUX, DK ;

FANSLOW, WC ;

BELMONT, J ;

SPRIGGS, MK .

SCIENCE, 1993, 259 (5097) :990-993

[4] A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function [J].

Anderson, DM ;

Maraskovsky, E ;

Billingsley, WL ;

Dougall, WC ;

Tometsko, ME ;

Roux, ER ;

Teepe, MC ;

DuBose, RF ;

Cosman, D ;

Galibert, L .

NATURE, 1997, 390 (6656) :175-179

[5] THE CD40 LIGAND, GP39, IS DEFECTIVE IN ACTIVATED T-CELLS FROM PATIENTS WITH X-LINKED HYPER-IGM SYNDROME [J].

ARUFFO, A ;

FARRINGTON, M ;

HOLLENBAUGH, D ;

LI, X ;

MILATOVICH, A ;

NONOYAMA, S ;

BAJORATH, J ;

GROSMAIRE, LS ;

STENKAMP, R ;

NEUBAUER, M ;

ROBERTS, RL ;

NOELLE, RJ ;

LEDBETTER, JA ;

FRANCKE, U ;

OCHS, HD .

CELL, 1993, 72 (02) :291-300

[6] THE CD40 ANTIGEN AND ITS LIGAND [J].

BANCHEREAU, J ;

BAZAN, F ;

BLANCHARD, D ;

BRIERE, F ;

GALIZZI, JP ;

VANKOOTEN, C ;

LIU, YJ ;

ROUSSET, F ;

SAELAND, S .

ANNUAL REVIEW OF IMMUNOLOGY, 1994, 12 :881-922

[7] Cell surface recycling of internalized antigen permits dendritic cell priming of B cells [J].

Bergtold, A ;

Desai, DD ;

Gavhane, A ;

Clyne, R .

IMMUNITY, 2005, 23 (05) :503-514

[8] Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells [J].

Bettelli, E ;

Carrier, YJ ;

Gao, WD ;

Korn, T ;

Strom, TB ;

Oukka, M ;

Weiner, HL ;

Kuchroo, VK .

NATURE, 2006, 441 (7090) :235-238

[9] Ranking the role of RANK ligand in apoptosis [J].

Bharti, AC ;

Aggarwal, BB .

APOPTOSIS, 2004, 9 (06) :677-690

[10] Signaling by CD40 and its mimics in B cell activation [J].

Bishop, GA ;

Hostager, BS .

IMMUNOLOGIC RESEARCH, 2001, 24 (02) :97-109

← 1 2 3 4 5 6 7 8 9 10 →